The current analyst and expert consensus on Del Mar is Strong Buy with 0 strong sell and 3 strong buy opinions. The current projected target price consensus is 14.84 with 5 analysts opinions. The most common way Del Mar Pharmaceuticals analysists use to provide recommendation to public is financial statements analysis. Many experts also interview Del Mar executives and customers to further validate their buy or sell advice. Please note, the number of analysists providing the opinion is not sufficient to provide adequate consensus on Del Mar. We encourage you to use your own analysis of Del Mar Pharmaceuticals to validate this buy or sell advice. Del Mar buy or sell recommendation module provides average expert sentiment on the projected Del Mar Pharmaceuticals target price to derive its highest and lowest estimates based on projected price volatility of 3.335. Additionally see Macroaxis Advice on Del Mar to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.